Join our mailing list for FREE to receive research breakthroughs, news and insights direct to your inbox: hubs.la/Q03pv5qK0

The management of coronary artery disease in patients undergoing TAVR is evolving. This review explores the latest evidence on coronary revascularisation and why an individualised approach may help optimise patient care. Read more: hubs.la/Q04qlmnP0 #Cardiology #TAVR

When surgery is not an option, transcatheter closure may offer a lifesaving alternative. Read this case report exploring the successful treatment of ventricular septal rupture following myocardial infarction. Read more: hubs.la/Q04pRLTr0 #MyocardialInfarction #CaseReport

What if interventional cardiology could treat plaque before it causes a heart attack? In this interview, Dr Salvatore Brugaletta discusses the shift from treating obstruction to preventing events - and the trials that could redefine the field. 🔗: hubs.la/Q04ngDjF0

Air pollution has been linked to a growing list of cardiovascular conditions. Now, new evidence suggests long-term exposure may also increase the risk of aortic stenosis by up to 60%. Find out more: hubs.la/Q04m0qgJ0

From advances in transcatheter valve interventions to AI-powered decision support and new long-term survival data, @PCRonline congress 2026 delivered key insights shaping the future of interventional cardiology. Explore the highlights and read more here: hubs.la/Q04jy5Rk0

At #EuroPCR2026, researchers reported AI-assisted OCT significantly improved clinician confidence during PCI decision-making. The findings suggest AI support could help narrow the experience gap between newer and experienced OCT users. Read more: hubs.la/Q04hDKC80

At #EuroPCR2026, a major patient-level meta-analysis found PCI with drug-eluting stents matched CABG for long-term survival in left main coronary artery disease. The findings could further shape contemporary revascularization strategies. Explore more: hubs.la/Q04hswQj0

Could local coronary inflammation help identify high-risk PCI patients earlier? Presented at #EuroPCR2026, new research highlights the value of pericoronary fat attenuation index (FAI) in predicting adverse outcomes after PCI. Explore the data: hubs.la/Q04hgjqH0

We’re heading to Paris for #EuroPCR2026. From LIVE cases to AI and breakthrough cardiovascular technologies, the EMJ team will be covering the innovations shaping the future of interventional cardiology. Join EMJ Cardiology for full congress coverage: hubs.la/Q04h7MVC0

Domestic abuse rates are higher among nurses and midwives than the general population, but why? Read more on EMJ: hubs.la/Q04cL1nr0

New evidence shows that impaired heart rate recovery is an independent predictor of periprocedural myocardial infarction in patients undergoing stent surgery. This noninvasive measure could strengthen pre-procedural risk stratification hubs.la/Q03_7QBl0

Can a new tool transform how cardiologists treat de novo small vessel disease? Find out on EMJ: hubs.la/Q03Sm52S0

Your expertise matters. Use the EQOH Score to tell us how our content supports your clinical practice - and help us make it even better. Rate our content today: hubs.la/Q03QLhx30

Tired of searching for the latest breakthroughs? What if we could make the most essential knowledge accessible to you - just a tap away? Follow us on Instagram: hubs.la/Q03NGy8L0

How does the DurAVR heart valve compare in hydrodynamic performance to current TAVI standards? Find out: hubs.la/Q03NhTmF0

Uncover more of innovator, author, and leader Srihari S. Naidu, Cardiac Catheterization lab's thoughts in his full interview with EMJ: hubs.la/Q03BkBng0

Age matters in transcatheter PFO closure outcomes. Recent findings show that older patients have higher rates of death and recurrent stroke after the procedure. Discover more: hubs.la/Q03B5nj80

Discover our latest Interventional Cardiology journal: hubs.la/Q03vMpG90 Inside, read all the latest insights from @EuroInterventio EuroPCR and beyond, including interviews with Srihari S. Naidu, Salvatore Brugaletta and more.

Drug-coated balloons are playing an evolving role in shaping future scaffold-free percutaneous coronary intervention strategies. Find out how: hubs.la/Q03vBbx80

“Despite over 30 years of vascular access research and relative maturity in the field, there remain opportunities for improvement." Curious to uncover more of @arnoldseto, @SCAI's thoughts on innovations in vascular access? Read his full interview: hubs.la/Q03vnvhY0